Display options
Cite
Nieuwenhuijsen K, Verbeek JH, Neumeyer-Gromen A, et al. Interventions to improve return to work in depressed people. Cochrane Database Syst Rev. 2020;10:CD006237doi: 10.1002/14651858.CD006237.pub4.
Nieuwenhuijsen, K., Verbeek, J. H., Neumeyer-Gromen, A., Verhoeven, A. C., Bültmann, U., & Faber, B. (2020). Interventions to improve return to work in depressed people. The Cochrane database of systematic reviews, 10CD006237. https://doi.org/10.1002/14651858.CD006237.pub4
Nieuwenhuijsen, Karen, et al. "Interventions to improve return to work in depressed people." The Cochrane database of systematic reviews vol. 10 (2020): CD006237. doi: https://doi.org/10.1002/14651858.CD006237.pub4
Nieuwenhuijsen K, Verbeek JH, Neumeyer-Gromen A, Verhoeven AC, Bültmann U, Faber B. Interventions to improve return to work in depressed people. Cochrane Database Syst Rev. 2020 Oct 13;10:CD006237. doi: 10.1002/14651858.CD006237.pub4. PMID: 33052607; PMCID: PMC8094165.
Copy Download .nbib Format: NLM
Share it on

Cochrane Database Syst Rev. 2020 Oct 13;10:CD006237. doi: 10.1002/14651858.CD006237.pub4.

Interventions to improve return to work in depressed people.

The Cochrane database of systematic reviews

Karen Nieuwenhuijsen, Jos H Verbeek, Angela Neumeyer-Gromen, Arco C Verhoeven, Ute Bültmann, Babs Faber

Affiliations

  1. Department of Public and Occupational Health, Coronel Institute of Occupational Health, Amsterdam Public Health research institute, Amsterdam UMC, University of Amsterdam, Academic Medical Center, Amsterdam, Netherlands.
  2. Cochrane Work Review Group, Department of Public and Occupational Health, Amsterdam Public Health research institute, Amsterdam UMC, University of Amsterdam, Academic Medical Center, Amsterdam, Netherlands.
  3. Deutsche Krankenhausgesellschaft (The German Hospital Federation), Berlin, Germany.
  4. SGBO, Radboud University Medical Centre, Nijmegen, Netherlands.
  5. Department of Health Sciences, Community and Occupational Medicine, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
  6. Coronel Institute of Occupational Health/Dutch Research Center for Insurance Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands.

PMID: 33052607 PMCID: PMC8094165 DOI: 10.1002/14651858.CD006237.pub4

Abstract

BACKGROUND: Work disability such as sickness absence is common in people with depression.

OBJECTIVES: To evaluate the effectiveness of interventions aimed at reducing work disability in employees with depressive disorders.

SEARCH METHODS: We searched CENTRAL (The Cochrane Library), MEDLINE, Embase, CINAHL, and PsycINFO until April 4th 2020.

SELECTION CRITERIA: We included randomised controlled trials (RCTs) and cluster-RCTs of work-directed and clinical interventions for depressed people that included days of sickness absence or being off work as an outcome. We also analysed the effects on depression and work functioning.

DATA COLLECTION AND ANALYSIS: Two review authors independently extracted the data and rated the certainty of the evidence using GRADE. We used standardised mean differences (SMDs) or risk ratios (RR) with 95% confidence intervals (CI) to pool study results in studies we judged to be sufficiently similar.  MAIN RESULTS: In this update, we added 23 new studies. In total, we included 45 studies with 88 study arms, involving 12,109 participants with either a major depressive disorder or a high level of depressive symptoms. Risk of bias The most common types of bias risk were detection bias (27 studies) and attrition bias (22 studies), both for the outcome of sickness absence. Work-directed interventions Work-directed interventions combined with clinical interventions A combination of a work-directed intervention and a clinical intervention probably reduces days of sickness absence within the first year of follow-up (SMD -0.25, 95% CI -0.38 to -0.12; 9 studies; moderate-certainty evidence). This translates back to 0.5 fewer (95% CI -0.7 to -0.2) sick leave days in the past two weeks or 25 fewer days during one year (95% CI -37.5 to -11.8). The intervention does not lead to fewer persons being off work beyond one year follow-up (RR 0.96, 95% CI 0.85 to 1.09; 2 studies, high-certainty evidence). The intervention may reduce depressive symptoms (SMD -0.25, 95% CI -0.49 to -0.01; 8 studies, low-certainty evidence) and probably has a small effect on work functioning (SMD -0.19, 95% CI -0.42 to 0.06; 5 studies, moderate-certainty evidence) within the first year of follow-up.  Stand alone work-directed interventions A specific work-directed intervention alone may increase the number of sickness absence days compared with work-directed care as usual (SMD 0.39, 95% CI 0.04 to 0.74; 2 studies, low-certainty evidence) but probably does not lead to more people being off work within the first year of follow-up (RR 0.93, 95% CI 0.77 to 1.11; 1 study, moderate-certainty evidence) or beyond (RR 1.00, 95% CI 0.82 to 1.22; 2 studies, moderate-certainty evidence). There is probably no effect on depressive symptoms (SMD -0.10, 95% -0.30 CI to 0.10; 4 studies, moderate-certainty evidence) within the first year of follow-up and there may be no effect on depressive symptoms beyond that time (SMD 0.18, 95% CI -0.13 to 0.49; 1 study, low-certainty evidence). The intervention may also not lead to better work functioning (SMD -0.32, 95% CI -0.90 to 0.26; 1 study, low-certainty evidence) within the first year of follow-up.   Psychological interventions A psychological intervention, either face-to-face, or an E-mental health intervention, with or without professional guidance, may reduce the number of sickness absence days, compared with care as usual (SMD -0.15, 95% CI -0.28 to -0.03; 9 studies, low-certainty evidence). It may also reduce depressive symptoms (SMD -0.30, 95% CI -0.45 to -0.15, 8 studies, low-certainty evidence). We are uncertain whether these psychological interventions improve work ability (SMD -0.15 95% CI -0.46 to 0.57; 1 study; very low-certainty evidence). Psychological intervention combined with antidepressant medication Two studies compared the effect of a psychological intervention combined with antidepressants to antidepressants alone. One study combined psychodynamic therapy with tricyclic antidepressant (TCA) medication and another combined telephone-administered cognitive behavioural therapy (CBT) with a selective serotonin reuptake inhibitor (SSRI). We are uncertain if this intervention reduces the number of sickness absence days (SMD -0.38, 95% CI -0.99 to 0.24; 2 studies, very low-certainty evidence) but found that there may be no effect on depressive symptoms (SMD -0.19, 95% CI -0.50 to 0.12; 2 studies, low-certainty evidence). Antidepressant medication only Three studies compared the effectiveness of SSRI to selective norepinephrine reuptake inhibitor (SNRI) medication on reducing sickness absence and yielded highly inconsistent results. Improved care Overall, interventions to improve care did not lead to fewer days of sickness absence, compared to care as usual (SMD -0.05, 95% CI -0.16 to 0.06; 7 studies, moderate-certainty evidence). However, in studies with a low risk of bias, the intervention probably leads to fewer days of sickness absence in the first year of follow-up (SMD -0.20, 95% CI -0.35 to -0.05; 2 studies; moderate-certainty evidence). Improved care probably leads to fewer depressive symptoms (SMD -0.21, 95% CI -0.35 to -0.07; 7 studies, moderate-certainty evidence) but may possibly lead to a decrease in work-functioning (SMD 0.5, 95% CI 0.34 to 0.66; 1 study; moderate-certainty evidence). Exercise Supervised strength exercise may reduce sickness absence, compared to relaxation (SMD -1.11; 95% CI -1.68 to -0.54; one study, low-certainty evidence). However, aerobic exercise probably is not more effective than relaxation or stretching (SMD -0.06; 95% CI -0.36 to 0.24; 2 studies, moderate-certainty evidence). Both studies found no differences between the two conditions in depressive symptoms.

AUTHORS' CONCLUSIONS: A combination of a work-directed intervention and a clinical intervention probably reduces the number of sickness absence days, but at the end of one year or longer follow-up, this does not lead to more people in the intervention group being at work. The intervention may also reduce depressive symptoms and probably increases work functioning more than care as usual. Specific work-directed interventions may not be more effective than usual work-directed care alone. Psychological interventions may reduce the number of sickness absence days, compared with care as usual. Interventions to improve clinical care probably lead to lower sickness absence and lower levels of depression, compared with care as usual. There was no evidence of a difference in effect on sickness absence of one antidepressant medication compared to another. Further research is needed to assess which combination of work-directed and clinical interventions works best.

Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

References

  1. J Clin Psychiatry. 2000 Apr;61(4):268-75 - PubMed
  2. Occup Environ Med. 2017 Dec;74(12):905-912 - PubMed
  3. Occup Environ Med. 2005 Feb;62(2):74-9 - PubMed
  4. Int J Group Psychother. 2011 Oct;61(4):539-55 - PubMed
  5. J Occup Environ Med. 2010 Aug;52(8):778-90 - PubMed
  6. Scand J Work Environ Health. 2019 Jan 1;45(1):33-41 - PubMed
  7. BMC Psychiatry. 2014 Oct 18;14:290 - PubMed
  8. Ind Health. 2010;48(4):495-502 - PubMed
  9. Clin Psychopharmacol Neurosci. 2014 Dec;12(3):180-8 - PubMed
  10. Internet Interv. 2019 May 03;17:100247 - PubMed
  11. Stat Med. 2002 Oct 15;21(19):2971-80 - PubMed
  12. JAMA. 2007 Sep 26;298(12):1401-11 - PubMed
  13. Can J Occup Ther. 2018 Feb;85(1):21-32 - PubMed
  14. J Psychiatr Res. 2017 Dec;95:28-36 - PubMed
  15. BMC Public Health. 2014 Aug 07;14:807 - PubMed
  16. J Affect Disord. 1996 Feb 12;37(1):31-41 - PubMed
  17. J Clin Psychopharmacol. 2011 Oct;31(5):569-76 - PubMed
  18. BMC Psychiatry. 2007 Dec 19;7:72 - PubMed
  19. J Negat Results Biomed. 2017 Aug 22;16(1):13 - PubMed
  20. Trials. 2015 Mar 17;16:98 - PubMed
  21. BMC Psychiatry. 2018 Jun 1;18(1):166 - PubMed
  22. Occup Environ Med. 2005 Oct;62(10):682-7 - PubMed
  23. Occup Environ Med. 2005 Aug;62(8):538-45 - PubMed
  24. J Occup Environ Med. 2017 Dec;59(12):1211-1220 - PubMed
  25. JAMA. 1989 Aug 18;262(7):914-9 - PubMed
  26. J Med Internet Res. 2015 May 13;17(5):e116 - PubMed
  27. Psychol Med. 2012 Feb;42(2):327-34 - PubMed
  28. CNS Spectr. 2019 Jun;24(3):322-332 - PubMed
  29. J Occup Environ Med. 2004 Jun;46(6 Suppl):S38-45 - PubMed
  30. Trials. 2011 Jan 13;12:11 - PubMed
  31. J Med Internet Res. 2009 May 11;11(2):e15 - PubMed
  32. Scand J Work Environ Health. 2014 Nov;40(6):582-96 - PubMed
  33. Nord J Psychiatry. 2015 Jan;69(1):57-66 - PubMed
  34. Behav Ther. 2012 Dec;43(4):801-11 - PubMed
  35. Front Psychol. 2017 Jan 06;7:2003 - PubMed
  36. Br J Psychiatry. 2015 Apr;206(4):332-8 - PubMed
  37. Am J Psychiatry. 2006 Sep;163(9):1569-76 - PubMed
  38. J Occup Rehabil. 2018 Mar;28(1):170-179 - PubMed
  39. Soc Sci Med. 1995 Nov;41(10):1447-62 - PubMed
  40. Scand J Work Environ Health. 2017 Sep 1;43(5):436-446 - PubMed
  41. J Occup Rehabil. 2012 Sep;22(3):312-21 - PubMed
  42. Occup Environ Med. 2011 Jun;68(6):400-7 - PubMed
  43. Cochrane Database Syst Rev. 2017 Mar 30;3:CD011618 - PubMed
  44. J Occup Environ Med. 2012 Feb;54(2):128-35 - PubMed
  45. Scand J Work Environ Health. 2014 Nov;40(6):569-81 - PubMed
  46. Aust N Z J Psychiatry. 2017 Aug;51(8):829-840 - PubMed
  47. BMC Psychiatry. 2013 Feb 18;13:61 - PubMed
  48. JAMA. 2001 Sep 19;286(11):1325-30 - PubMed
  49. Psychiatr Rehabil J. 2018 Sep;41(3):169-182 - PubMed
  50. Gen Hosp Psychiatry. 2010 May-Jun;32(3):337-40 - PubMed
  51. JMIR Mhealth Uhealth. 2016 Jan 26;4(1):e8 - PubMed
  52. J Med Internet Res. 2014 Jul 09;16(7):e168 - PubMed
  53. Arch Gen Psychiatry. 1979 Nov;36(12):1381-3 - PubMed
  54. Soc Sci Med. 2000 Jul;51(1):41-50 - PubMed
  55. J Adv Nurs. 1995 Oct;22(4):769-78 - PubMed
  56. Psychiatr Serv. 2015 Jun;66(6):570-7 - PubMed
  57. Am J Psychiatry. 2006 Sep;163(9):1561-8 - PubMed
  58. Cochrane Database Syst Rev. 2013 Sep 12;(9):CD004366 - PubMed
  59. J Occup Environ Med. 2008 Apr;50(4):401-10 - PubMed
  60. Soc Psychiatry Psychiatr Epidemiol. 2016 Nov;51(11):1525-1537 - PubMed
  61. Br J Soc Clin Psychol. 1967 Dec;6(4):278-96 - PubMed
  62. J Affect Disord. 2016 Jan 15;190:254-263 - PubMed
  63. Curr Opin Ophthalmol. 2013 May;24(3):183-9 - PubMed
  64. BMC Public Health. 2013 Feb 12;13:129 - PubMed
  65. J Affect Disord. 1991 Sep;23(1):35-41 - PubMed
  66. Int J Neuropsychopharmacol. 2019 Mar 1;22(3):173-179 - PubMed
  67. J Occup Health. 2004 Nov;46(6):448-54 - PubMed
  68. Health Technol Assess. 2005 Sep;9(37):1-104, iii - PubMed
  69. BMC Fam Pract. 2017 Jan 19;18(1):6 - PubMed
  70. Br J Psychiatry. 2011 Aug;199(2):132-9 - PubMed
  71. Psychol Med. 2016 Apr;46(6):1175-88 - PubMed
  72. Br J Psychiatry. 1979 Apr;134:382-9 - PubMed
  73. J Clin Psychiatry. 1998 Nov;59(11):608-19 - PubMed
  74. Psychiatr Serv. 2002 May;53(5):585-90 - PubMed
  75. Occup Environ Med. 2015 Oct;72(10):745-52 - PubMed
  76. J Occup Rehabil. 2015 Mar;25(1):127-40 - PubMed
  77. J Med Internet Res. 2017 Jun 15;19(6):e213 - PubMed
  78. Scand J Work Environ Health. 2018 Nov 1;44(6):631-638 - PubMed
  79. Med Care. 2004 Dec;42(12):1202-10 - PubMed
  80. Health Serv Res. 2002 Oct;37(5):1145-58 - PubMed
  81. J Affect Disord. 2011 Jul;132(1-2):37-47 - PubMed
  82. J Occup Health Psychol. 2015 Jan;20(1):1-14 - PubMed
  83. JAMA. 2000 Jan 12;283(2):212-20 - PubMed
  84. Psychol Med. 1998 May;28(3):693-701 - PubMed
  85. Lancet. 2012 Dec 15;380(9859):2197-223 - PubMed
  86. Depress Anxiety. 2001;13(1):1-10 - PubMed
  87. Psychother Psychosom. 2017;86(6):341-350 - PubMed
  88. Psychol Med. 2007 Mar;37(3):351-62 - PubMed
  89. Clin Rehabil. 2020 Feb;34(2):170-181 - PubMed
  90. Int Clin Psychopharmacol. 2012 Jan;27(1):17-26 - PubMed
  91. J Ment Health Policy Econ. 2009 Dec;12(4):195-204 - PubMed
  92. Occup Med (Lond). 2006 Jan;56(1):39-45 - PubMed
  93. Eur Neuropsychopharmacol. 2016 Feb;26(2):378-389 - PubMed
  94. J Clin Psychiatry. 2015 Feb;76(2):155-62 - PubMed
  95. PLoS One. 2017 May 8;12(5):e0176513 - PubMed
  96. Br J Psychiatry. 2010 Oct;197(4):297-304 - PubMed
  97. BMC Psychol. 2018 May 23;6(1):25 - PubMed
  98. Aust N Z J Psychiatry. 2016 Oct;50(10):1001-13 - PubMed
  99. Trials. 2013 Dec 24;14:442 - PubMed
  100. J Occup Rehabil. 2010 Sep;20(3):275-92 - PubMed
  101. BMC Public Health. 2018 May 22;18(1):599 - PubMed
  102. Occup Environ Med. 2012 Dec;69(12):870-6 - PubMed
  103. Cochrane Database Syst Rev. 2008 Apr 16;(2):CD006237 - PubMed
  104. Ann Clin Psychiatry. 2017 Feb;29(1):11-16 - PubMed
  105. Occup Environ Med. 2013 Apr;70(4):223-30 - PubMed
  106. BMJ Open. 2019 Nov 5;9(10):e032119 - PubMed
  107. J Affect Disord. 2018 Oct 1;238:317-326 - PubMed
  108. Psychother Psychosom. 2008;77(6):351-7 - PubMed
  109. Pharmacoeconomics. 1998 Jan;13(1 Pt 2):157-69 - PubMed
  110. PLoS Clin Trials. 2007 Jun 01;2(6):e26 - PubMed
  111. Occup Environ Med. 2013 Apr;70(4):252-60 - PubMed
  112. J Occup Health Psychol. 2012 Apr;17(2):220-34 - PubMed
  113. Trials. 2017 Dec 2;18(1):578 - PubMed
  114. Br J Psychiatry. 1964 Sep;110:641-7 - PubMed
  115. BMJ. 2001 Apr 21;322(7292):989-91 - PubMed
  116. Schizophr Res. 2019 Jan;203:41-48 - PubMed
  117. Br J Psychiatry. 2004 Jul;185:55-62 - PubMed
  118. Gen Hosp Psychiatry. 2015 Jul-Aug;37(4):352-9 - PubMed
  119. Scand J Work Environ Health. 2013 Mar 1;39(2):144-54 - PubMed
  120. Int Clin Psychopharmacol. 1996 Jun;11 Suppl 3:89-95 - PubMed
  121. J Affect Disord. 2013 Jun;148(2-3):272-7 - PubMed
  122. J Affect Disord. 2018 Feb;227:406-415 - PubMed
  123. Hum Psychopharmacol. 2012 Jan;27(1):47-56 - PubMed
  124. Occup Environ Med. 2018 Jan;75(1):52-58 - PubMed
  125. J Affect Disord. 2015 Oct 1;185:180-7 - PubMed
  126. Pharmacoeconomics. 2005;23(2):155-67 - PubMed
  127. J Affect Disord. 2014 Sep;166:307-14 - PubMed
  128. Pharmacoeconomics. 2008;26(11):969-81 - PubMed
  129. Community Ment Health J. 1998 Feb;34(1):71-82 - PubMed
  130. Am J Ind Med. 2006 May;49(5):394-401 - PubMed
  131. J Psychiatr Res. 2015 Jul-Aug;66-67:84-94 - PubMed
  132. Psychother Psychosom. 2020;89(2):90-105 - PubMed
  133. Occup Environ Med. 2017 Oct;74(10):717-725 - PubMed
  134. PLoS One. 2012;7(4):e35330 - PubMed
  135. J Clin Psychiatry. 2005 Oct;66(10):1312-20 - PubMed
  136. Soc Sci Med. 2000 Jul;51(2):243-9 - PubMed
  137. J Clin Psychiatry. 2009 Jun;70(6):790-800 - PubMed
  138. J Occup Rehabil. 2017 Sep;27(3):456-466 - PubMed
  139. Aust Occup Ther J. 2013 Apr;60(2):85-92 - PubMed
  140. J Ment Health Policy Econ. 2015 Dec;18(4):175-83 - PubMed
  141. Soc Psychiatry Psychiatr Epidemiol. 2017 Jan;52(1):1-10 - PubMed
  142. Eur J Public Health. 2007 Apr;17(2):214-20 - PubMed
  143. BMJ Open. 2019 Apr 8;9(4):e025138 - PubMed
  144. BMC Fam Pract. 2018 Feb 09;19(1):28 - PubMed
  145. PLoS One. 2013 Jul 29;8(7):e69637 - PubMed
  146. Psychother Psychosom Med Psychol. 2015 Aug;65(8):321-6 - PubMed
  147. Psychol Med. 2014 Mar;44(4):741-52 - PubMed
  148. Br J Psychiatry. 2000 May;176:421-8 - PubMed
  149. JAMA Netw Open. 2020 Feb 5;3(2):e200075 - PubMed
  150. Scand J Prim Health Care. 2017 Jun;35(2):126-136 - PubMed
  151. Occup Environ Med. 2014 Jan;71(1):21-9 - PubMed
  152. Occup Med (Lond). 2002 Dec;52(8):485-90 - PubMed
  153. Med J Aust. 2014 Oct 6;201(7):417-9 - PubMed
  154. J Occup Health Psychol. 2019 Feb;24(1):198-212 - PubMed
  155. Int Clin Psychopharmacol. 2001 Nov;16(6):317-24 - PubMed
  156. CNS Drugs. 2016 May;30(5):405-17 - PubMed
  157. Evid Based Ment Health. 2009 Nov;12(4):109 - PubMed
  158. BMC Psychiatry. 2013 May 24;13:147 - PubMed
  159. J Ment Health Policy Econ. 2002 Sep;5(3):115-20 - PubMed
  160. BMC Public Health. 2013 Mar 06;13:193 - PubMed
  161. Pharmacotherapy. 2003 Sep;23(9):1175-85 - PubMed
  162. JAMA Psychiatry. 2016 Jun 1;73(6):639-40 - PubMed
  163. PLoS One. 2012;7(10):e48316 - PubMed
  164. Br J Psychiatry. 1985 Sep;147:246-9 - PubMed
  165. J R Soc Med. 1987 Nov;80(11):689-91 - PubMed
  166. BMC Psychiatry. 2016 May 06;16:131 - PubMed
  167. J Affect Disord. 2017 Jan 01;207:212-220 - PubMed
  168. Int Clin Psychopharmacol. 2004 May;19(3):125-34 - PubMed
  169. J Occup Rehabil. 2020 Mar;30(1):22-39 - PubMed
  170. Gen Hosp Psychiatry. 2000 May-Jun;22(3):153-62 - PubMed
  171. JAMA. 2001 Dec 19;286(23):2947-55 - PubMed
  172. Psychopharmacol Bull. 1997;33(1):13-6 - PubMed
  173. BMC Psychiatry. 2018 Sep 26;18(1):312 - PubMed
  174. Work. 2012;43(2):203-10 - PubMed
  175. Int Clin Psychopharmacol. 2007 Mar;22(2):107-15 - PubMed
  176. Arch Gen Psychiatry. 2011 Jan;68(1):33-41 - PubMed
  177. Nord J Psychiatry. 2013 Feb;67(1):59-68 - PubMed
  178. BMC Complement Altern Med. 2014 Mar 11;14:95 - PubMed
  179. Psychother Psychosom. 2006;75(3):177-82 - PubMed

Substances

MeSH terms

Publication Types